Loading clinical trials...
Loading clinical trials...
This is a prospective study to investigate the potential efficacy of 68Ga-FAPI PET/CT for recurrence detection of epithelial ovarian cancer in comparison with 18F-FDG PET/CT.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
RenJi Hospital
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more
NCT06964009 · Ovarian Cancer, Ovarian Carcinoma, and more
NCT00539162 · Ovarian Cancer
NCT06915025 · Epithelial Ovarian Cancer, Ovarian Cancer, and more
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions